1. Home
  2. LOAN vs NVNO Comparison

LOAN vs NVNO Comparison

Compare LOAN & NVNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LOAN
  • NVNO
  • Stock Information
  • Founded
  • LOAN 1989
  • NVNO 1987
  • Country
  • LOAN United States
  • NVNO United States
  • Employees
  • LOAN N/A
  • NVNO N/A
  • Industry
  • LOAN Real Estate Investment Trusts
  • NVNO Medical/Dental Instruments
  • Sector
  • LOAN Real Estate
  • NVNO Health Care
  • Exchange
  • LOAN Nasdaq
  • NVNO Nasdaq
  • Market Cap
  • LOAN 57.7M
  • NVNO 61.9M
  • IPO Year
  • LOAN 1999
  • NVNO N/A
  • Fundamental
  • Price
  • LOAN $5.39
  • NVNO $2.45
  • Analyst Decision
  • LOAN
  • NVNO
  • Analyst Count
  • LOAN 0
  • NVNO 0
  • Target Price
  • LOAN N/A
  • NVNO N/A
  • AVG Volume (30 Days)
  • LOAN 34.1K
  • NVNO 94.7K
  • Earning Date
  • LOAN 04-29-2025
  • NVNO 05-07-2025
  • Dividend Yield
  • LOAN 8.63%
  • NVNO N/A
  • EPS Growth
  • LOAN 2.37
  • NVNO N/A
  • EPS
  • LOAN 0.49
  • NVNO N/A
  • Revenue
  • LOAN $7,351,609.00
  • NVNO N/A
  • Revenue This Year
  • LOAN N/A
  • NVNO N/A
  • Revenue Next Year
  • LOAN $2.18
  • NVNO $409.09
  • P/E Ratio
  • LOAN $10.90
  • NVNO N/A
  • Revenue Growth
  • LOAN 1.12
  • NVNO N/A
  • 52 Week Low
  • LOAN $4.74
  • NVNO $2.03
  • 52 Week High
  • LOAN $6.05
  • NVNO $6.48
  • Technical
  • Relative Strength Index (RSI)
  • LOAN 48.35
  • NVNO 44.81
  • Support Level
  • LOAN $4.83
  • NVNO $2.05
  • Resistance Level
  • LOAN $5.38
  • NVNO $2.44
  • Average True Range (ATR)
  • LOAN 0.25
  • NVNO 0.23
  • MACD
  • LOAN -0.02
  • NVNO 0.02
  • Stochastic Oscillator
  • LOAN 49.62
  • NVNO 53.42

About LOAN Manhattan Bridge Capital Inc

Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.

About NVNO enVVeno Medical Corporation

enVVeno Medical Corp is a medical device company focused on the development of bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. Its product, the VenoValve, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).

Share on Social Networks: